1 / 6

Breast Biopsy Devices Market Trend and Forecast To 2027, Key Player - Hologic In

The global breast biopsy devices market is growing at 8.5% CAGR owing to rising prevalence of breast cancer in female population globally is one of the key rivers for the growth of the global breast biopsy devices market. The increase in number of breast cancer screening programs due to initiatives by government and rising demand for minimally invasive and non-invasive procedures due to the benefits offered like speedy recovery and less pain will propel the growth of the breast biopsy devices market. Furthermore, the increasing awareness about early detection of breast cancer and favourable re

Research1
Télécharger la présentation

Breast Biopsy Devices Market Trend and Forecast To 2027, Key Player - Hologic In

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Breast Biopsy Devices Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. Global Breast Biopsy Devices Market The global breast biopsy devices market is growing at 8.5% CAGR owing to rising prevalence of breast cancer in female population globally is one of the key rivers for the growth of the global breast biopsy devices market. The increase in number of breast cancer screening programs due to initiatives by government and rising demand for minimally invasive and non-invasive procedures due to the benefits offered like speedy recovery and less pain will propel the growth of the breast biopsy devices market. Furthermore, the increasing awareness about early detection of breast cancer and favourable reimbursement scenario will fuel the growth in the breast biopsy devices market. The growing population, increasing expenditure on healthcare and initiatives by public organizations regarding female health problems will accelerate the growth of the breast biopsy devices market. Nevertheless, the innovation of liquid biopsy and promising clinical trail will create promising opportunities for growth in the global breast biopsy devices market.

  4. Global Breast Biopsy Devices Market The COVID-19 pandemic has had a negative impact on breast biopsy devices market owing to limited access to clinics & hospitals, social distancing norms, and lockdown measures. Based on product, the biopsy needles contributes to the largest share in the breast biopsy devices market owing to the increased adoption of image guided procedures in developed and emerging economies, rising demand for minimally invasive procedures, and the introduction of technologically advanced and novel designs. North America dominates the breast biopsy devices market owing to the rising cases of breast cancer, growing geriatric population, increased expenditure on healthcare, economic prosperity, and expansion of private healthcare sector.

  5. Global Breast Biopsy Devices Market Hologic has received the European CE mark for Breva Breast Biopsy System with CorLumina Imaging Technology. The system is designed to improve biopsy accuracy, improve patient satisfaction, and streamline the biopsy suite workflow through real-time imaging. The prominent players in the breast biopsy devices industry include Becton, Dickinson and Company, Cook Medical Incorporated, Hologic Inc., Medtronic PLC., Sterylab S.R.L., Danaher Corporation, Siemens AG, Intact Medical Corporation, and Planmed Oy.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/breast-biopsy-devices-market/request-sample www.vynzresearch.com

More Related